Literature DB >> 2018558

Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice.

H Safayhi1, T Mack, H P Ammon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2018558     DOI： 10.1016/0006-2952(91)90575-p

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells.

Authors:  Jian-Jun Liu; Baohua Huang; Shing Chuan Hooi
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

2.  Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.

Authors:  E R Sailer; L R Subramanian; B Rall; R F Hoernlein; H P Ammon; H Safayhi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.

Authors:  Mark Barton Frank; Qing Yang; Jeanette Osban; Joseph T Azzarello; Marcia R Saban; Ricardo Saban; Richard A Ashley; Jan C Welter; Kar-Ming Fung; Hsueh-Kung Lin
Journal:  BMC Complement Altern Med       Date:  2009-03-18       Impact factor: 3.659

4.  Effect of Boswellia serrata supplementation on blood lipid, hepatic enzymes and fructosamine levels in type2 diabetic patients.

Authors:  Akram Ahangarpour; Hamid Heidari; Ramezani Ali Akbari Fatemeh; Mostafa Pakmehr; Hajeye Shahbazian; Iraj Ahmadi; Zahra Mombeini; Babadi Hajani Mehrangiz
Journal:  J Diabetes Metab Disord       Date:  2014-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.